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In studies of human cataracts, Dische and Zil (I) first noted that the proteins of the 
human cataractous lens were associated with a marked increase in sulflaydryl oxidation 
to  form disulfide bonds. The correlation of disulfide  bonds and cataract  formation 
has been combined subsequently by a  number of other workers studying animal and 
human cataracts (2-6). These disulfide bonds can act as intermolecular crosslinks and 
have been proposed to be partly responsible for the polymerization of the lens proteins 
in the formation of high molecular weight aggregates. Protein aggregates > 150  ×  106 
dahons have been detected in aged normal lenses as well as in human cataracts (7, 8) 
and recently a disulfide-linked high molecular weight protein associated with the fiber 
cell membrane has been isolated from human cataracts and characterized (9). One of 
the physical characteristics of protein aggregates of this size is their ability to scatter 
light.  Based  on  theoretical  consideration,  Benedek  (10)  has  hypothesized  that  the 
formation of protein  aggregates of tool wt  >  50  ×  106 dahons  could scatter  light 
sufficiently to account for cataract formation in the lens.  This is substantiated by the 
work of Spector and colleagues (11) who found that light backscattering of the lens 
parallels the increase in high molecular weight protein in the aging lens. 
In  contrast  to  studies  of human  senile  cataractogenesis,  little  is  known  of the 
physical  state  of the  lens  proteins  of the  sugar  cataracts  formed  in  diabetes  and 
galactosemia.  Preliminary evidence of electron  dense  aggregates and  a  decrease  in 
low molecular weight proteins have been reported in cataracts of galactosemic rats 
and point to a  potential role of protein aggregates in sugar cataract formation (12- 
14). The prevalent theory to account for the cataract formation in these experimental 
models is  the accumulation of polyols (sorbitol  and galactitol)  in  the cells  which is 
believed  to  cause  osmotic swelling,  vacuolization,  and  rupture  of lens  fibers  (15). 
However, the mechanism responsible  for the  formation of light  scattering elements 
after  the  putative  osmotic  shock  have  not  been  demonstrated.  We  have  recently 
proposed that in the diabetic cataract of the rat, the aggregation of lens proteins via 
disulfide  bonds  is  accelerated  after  the  increased  nonenzymatic  glycosylation of 
proteins under hyperglycemic conditions (16). 
In the present work, we have extended our in vitro studies to an examination of the 
lens  proteins  of cataracts  from  diabetic  and  galactosemic rats  for  the  presence  of 
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nonenzymatic glycosylation of e-amino groups of lysine residues and high molecular 
weight protein aggregates linked by disulfide bonds. In addition, the effect of reducing 
agents on  the light scattering properties of protein solution from  cataracts was  also 
studied. 
Methods 
Chemicals.  Dithioerythritol, Tris, and alloxan were obtained from Sigma Chemical Co., St. 
Louis, Mo.  Dimercaptosuccinic acid, thioglycolic acid, penicillamine, and  glutathione were 
supplied by Aldrich Chemical Co.,  Inc., Milwaukee, Wis. /~-mercaptoethanol was obtained 
from  Eastman  Kodak  Co.,  Rochester,  N.  Y.  Samples of purified  and  isotopically labeled 
Adenovirus and SV 40 virus were kindly provided by Dr. J.  M.  Blanchard. n-galaetose was 
obtained from Eastern Chemical, Div. of Guardian Chemical Corp., Hauppauge, N. Y. 
Cataractous  Lenses.  Lenses were obtained from normal, diabetic, and galactosemic female 
Sprague-Dawley rats (Taconic Farms, Germantown, N. Y.). Diabetes was induced by intrave- 
nous injection of a  freshly prepared solution of alloxan (40  mg/kg body weight, dissolved in 
0.01  M  sodium phosphate buffer, pH 3.5)  into female rats (60 g). Galactosemic cataracts were 
induced by feeding female rats  (100  g)  with  a  diet  (Purina  Lab Chow)  containing 33%  n- 
galactose. Nuclear cataracts appeared 8-10  wk after the onset  of diabetes or 3-5  wk after 
galaetose feeding. The  lenses were  tested  immediately after appearance of the  first nuclear 
opacities. 
Rat Lens Suspension.  Fresh rat lenses were deeapsulated and placed into a test tube containing 
1.5 ml buffer A  (Tris.HCl 0.1  M, pH 8.3)  per lens. The buffer had been previously deaerated 
and equilibrated with nitrogen. The lenses were gently teased apart with Pasteur pipettes and 
stirred with  a  stream  of nitrogen applied at  the surface of the  liquid until  a  homogenous 
suspension  of the  cataractous  proteins  was  obtained  (-~45  rain).  Loss  of liquid  through 
evaporation was replaced. After disruption of the lens, insoluble material was allowed to settle 
by gravity for 60 min. The supernate was used for the experiments. 
Absorbance of Light by Rat Lens Suspension.  The effect of reducing agents on the absorbanee of 
light by cataraetous rat lens suspension was measured at 550 nm using a  Zeiss PM6 spectro- 
photometer (Carl Zeiss, Inc., New York). A 0.75-ml aliquot of the lens suspension was placed 
into a  1-cm quartz cuvette and the reducing agent, dissolved in buffer A, was added to a final 
concentration of 50 raM. The solution was rapidly mixed and the absorbance was measured at 
regular intervals. The control and reduced samples of the experiments were performed simul- 
taneously on the same batch of lens proteins. 
Sucrose Density  Gradient  Centrifugation.  Sucrose  density gradients of 5-60%  were  prepared 
according to the procedure of Takemoto and Azari (6). 500/~1 of the rat lens suspension (with 
or without 30 mM dithioerythritoi (DTE)) x were layered on the top of the gradient which in 
addition to the sucrose contained buffer A  (with or without 30 mM DTE). The samples were 
centrifuged at 25,000 rpm for  18 h  at 20°C using a  SW 27 rotor in a  Spinco model L2-65N 
(Div. of Beckman Instruments, Palo Alto, Calif.) ultracentrifuge. The tubes were perforated at 
the  bottom with  a  20-g needle and  6-drop  fractions were collected.  1 ml  of buffer A  was 
subsequently added to each tube and the optical density measured at 280 nm. When DTE was 
present, each fraction was dialyzed twice (Speetrapor No. 3 tubing) against 4,000 ml buffer to 
remove the DTE, allowing the protein concentration to be measured at 280 nm. 
Gel Filtration  Chromatography.  After centrifugation at 400 g for 10 rain at room temperature, 
an aliquot of 500/~1 of the supernate of lens proteins from normal and cataractous lens was 
loaded  onto  a  Sepharose  2B  column  (40  ×  1 era)  (Pharmaeia  Fine  Chemicals,  Div.  of 
Pharmaeia Inc., Piscataway, N. J.) previously equilibrated with Tris HCI buffer 0.1 M, pH 8.6. 
The column was eluted with this same buffer at a flow rate of 4 ml/h. The absorbanee at 280 
nm was monitored in the fractions (1.2  ml) to which 50/~1 of NaOH,  10 M, were added to 
prevent  spurious  readings  through  light  scattering.  The  void  volume  of the  column  was 
determined with blue dextran. 
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Quantificatmn ofGlycosylated Lysine Residues.  Each cataractous or normal lens was homogenized 
in 0.05  M sodium phosphate buffer, pH 7.0. The homogenate was separated into soluble and 
insoluble fractions by centrifugation at 6,500 g 45 rain., and the fractions were reduced with 2 
mg tritiated  NaBH4 (8 #Ci/mmol). This both labeled the glycosyl adduct and prevented its 
dissociation. Excess borohydride was removed by dialysis at 4°C for 3 d. 
Modified lysine residues were detected by amino acid analysis with a Beckman model 119C 
analyzer (Beckman Instruments, Inc., Fullerton, Calif.)  (16). Stream division was used for the 
recovery of radioactive  products.  The  elution  time  of C-amino  galactosyl  lysine  (N6-1-(1- 
deoxygalactitolyl)-lysine) was the same as the glucosyl adduct whether it was obtained from a 
standard  synthesized  from  a-t-boc-lysine  (17),  or  from  an  acid  hydrolyzed sample  of lens 
crystallins which contained ~4C-galactose. 
The  relative  amounts  of modified  lysines  were  determined  by  measuring  the  tritium 
incorporated into the glycosylated lysine residues after NaB3H4 reduction. The fraction of lysine 
residues which were modified was estimated  from peak areas of the chromatograms. Protein 
concentration was measured by the method of Lowry et al.  (18) using bovine serum albumin 
as a standard. 
Results 
The formation of sugar cataracts has been hypothesized to involve the nonenzymatic 
glycosylation of the e-amino groups of lysine residues  on crystallins,  followed by the 
formation of high molecular weight protein aggregates. 
The amount of glycosylated lysine residues was measured in normal and cataractous 
lenses from galactosemie and diabetic animals  (Table I). Lysine residues in both the 
soluble  and  insoluble  proteins  of the  cataractous  lenses  were  modified  to  a  much 
greater degree than the normal lenses. Four to six times more tritium was incorporated 
into the crystallins of the galactose cataracts. This corresponds to the modification of 
7-8%  of the  lysine  residues  or 0.3  mol/mol  protein  (assuming  a  mol wt  of 20,000 
dahons/subunit).  At  the  time  of cataract  formation  in  the  diabetic  animals,  the 
amount  of modified  lysines  was  8-14  times  that  found  in  the  control  lenses.  This 
represents  the  modification  of  10-15%  of the  total  lysine  residues  or 0.6  mol/mol 
protein. 
To  investigate  the  mechanism  responsible  for light  scattering  in  the  cataractous 
lenses  of  diabetic  and  galactosemic  animals  it  was  necessary  to  prepare  a  lens 
homogenate  containing  the  scattering  elements  as  close  to  their  original  state  as 
possible. The use of a tissue homogenizer on normal rat lens leads to the formation of 
tissue  fragments  which  scatter  light  (Fig.  1 a).  This  artifactual  opacity  renders  the 
preparation  unsuitable  for analysis  of the  light  scattering  elements.  However,  if a 
normal rat  lens is teased smoothly apart  in a  deaerated buffer stirred by a  stream of 
nitrogen,, the insoluble  material  will settle  and a  clear solution of lens proteins  (Fig. 
1 b) is obtained. This method was used to prepare diabetic or galactosemic cataracts. 
A  light  scattering  suspension  of lens  proteins  was obtained  from diabetic  cataracts 
(Fig.  1 c). Upon addition of 30 mM DTE, a  large part of the turbidity of the solution 
could be reversed  (Fig.  1 d). A  turbid solution which could similarly be reversed with 
DTE, was obtained  from the cataractous lens of galactosemic rats  (not shown). The 
effect of various reducing agents on the amount of light scattering in the suspension 
of cataractous  lens  proteins  was  studied  by measuring  the  absorbance  at  550  nm. 
DTE,  followed  by thioglycolic acid  and  penieillamine,  were  found  to be  the  most 
effective in decreasing the scattering of light in solutions of lens proteins from diabetic 
cataracts  (Fig. 2). No effect was obtained with dimercaptosuccinic acid and glutathi- MONNIER, STEVENS,  AND CERAMI 
TABLE I 
nil-reduced e-Glycosylated Lysine Residues in Rat Lenses 
1101 
Ratio of specific 
Control  Galactosemic  activity galacto- 
semic/eontrol 
cpm/mg  cpm/mg 
Soluble  30.0 ±  08.9  230.6 ±  58.1  7.7 
Insoluble  85.5 ±  25.1  305.1 ±  63.9  3.6 
Total  112.5 ±  30.8  535.7 ±  96.8  4.8 
Control  Diabetic 
Ratio of specific ac- 
tivity  diabetic/con- 
trol 
cpm/mg  cpm/mg 
Soluble  37,6 ±  09.9  387.1 ±  058.5  10.3 
Insoluble  62.4 ±  05.1  720.3 ±  157.8  11.54 
Total  104.1 ±  15.6  1,107.4 +  155.1  10.6 
Radioactivity (all) per milligram protein associated with 1~- l-(-deoxyhexitolyl)lysine  eluted from an amino 
acid chromatography column. Homogenized rat lenses were separated into soluble and insoluble fractions. 
Cataractous  lenses from diabetic or galactosemic animals were compared with normal lenses from age- 
matched control animals. Values are mean cpm/mg protein ±  SD, n =  5. 
one. In galactosemic cataracts, both DTE and glutathione were effective in reducing 
the  light  scattering  of the suspension  (Fig.  3).  This  is  in  contrast  with  the  proteins 
from diabetic animals where glutathione was not effective. 
The effect of DTE was next tested on the separate soluble and insoluble fraction of 
the suspension obtained from galactose cataracts. After fractionation by centrifuging 
at 400 g,  l0 min., the insoluble portion was suspended in 3 ml of deaerated  buffer A 
containing Triton X-100  (Sigma, St.  Louis, Mo.)  and vortexed under nitrogen for  I 
min. This procedure assured that protein aggregates were solubilized from any tissue 
fragments. The effects of 50 mM DTE on the absorbance (550 nm) of the soluble and 
insoluble  fraction of the cataract  were then measured.  The cuvettes were constantly 
mixed between  the measurements  to prevent  settling of insoluble  material.  As dem- 
onstrated  in  Fig.  4,  the  absorbance  of  the  soluble  and  insoluble  fractions  from 
galactose cataracts could be decreased to 100% (base line) and 50%, respectively. The 
absorbance  of  the  unreduced  lens  fractions  remained  constant.  This  experiment 
confirms  the  results  obtained  with  the  unfractionated  preparation  described  first. 
Furthermore,  it can be estimated that the disulfide-linked  scattering of light contrib- 
uted by the insoluble fraction (58% of total lens proteins)  is 2.6 times greater than the 
soluble fraction (42% of total lens proteins). 
The possibility that  the light scattering of the cataractous suspension was a  result 
of high molecular weight aggregates was next investigated. Protein aggregates varying 
in  size  from  36  to  176  ×  106  daltons  were  detected  with  sucrose  gradients  in  the 
suspension  of proteins  from  galactose  cataracts  (Fig.  5).  Similarly,  high  molecular 
weight  species  were  detected  in  the  suspension  obtained  from  diabetic  lenses.  The 
addition  of DTE  (50  mM)  to  the  solution  of diabetic  lens  proteins  resulted  in  a 
decrease  in  the  amount  of high  molecular  weight  aggregates  and  a  concomitant 
increase in the amount of low molecular weight materials  (Fig. 6). 
The presence of high molecular weight aggregates was also detected in the soluble 1102  PROTEIN MODIFICATION IN SUGAR  CATARACTS 
FIG.  1.  (a)  Homogenate of normal rat  lenses prepared  under  nitrogen with ground glass tissue 
homogenizer. The buffer used was deaerated and equilibrated with nitrogen. (b-d) Suspensions of 
rat lens proteins prepared according to the method described in the text and incubated for 24 h at 
room temperature. The reversal experiment using DTE was performed on the same batch as the 
control. (b) normal rat lens. (c) eataractous lens of diabetic rat. (d) cataractous lens of diabetic rat 
incubated with 30 mM DTE. 
fraction  of galactose  cataracts  with  gel  filtration  chromatography on  Sepharose  2B 
(Fig. 7). The protein eluting in the void volume of the column have a  minimal size of 
~40 million daltons. Again reduction with 50 mM DTE lead to the disappearance of 
the protein peak in the void volume indicating that  these aggregates were linked by 
disulfide bonds. The high absorbance of low molecular weight species in Fig. 7 is due 
to the presence of DTE.  Protein aggregates were not detected  in the void volume of 
chromatograms of proteins from normal lenses. 
Discussion 
In a  recent study on the potential  role of nonenzymatic glycosylation for diabetic 
cataractogenesis  we reported  the  formation  of high  molecular  weight  aggregates  in 
solutions of bovine lens crystallins which had been incubated with glucose or glucose- 
6-phosphate.  The absorbance  at  550 nm of these  solutions  as well as the size of the 
aggregates  could  be  reversed  in  part  by  treatment  with  mild  reducing  agents.  We 
hypothesized that glycosylation enhanced the susceptibility of lens proteins to sulfhy- 
dryl oxidation.  We have  now extended  our in  vitro  studies  to cataractous  lenses  of 
diabetic and galactosemic rats. 
The results presented  here demonstrate  the presence of protein  aggregates of high 
molecular weight in experimental  cataracts induced by both diabetes  and galactose- 
mia.  These  aggregates  have  a  size of 40-176  million  daltons  and  according  to  the 
theory of Benedek  (10),  are large enough to scatter light. They are in part  linked by 10- 
E 
E 
O 
tt'3 
if3 
8 
E 
O 
o 
.o  0.5- 
MONNIER,  STEVENS,  AND CERAMI 
x-~.,,r-....  ~  -v  L  X  Control 
.  -  ~  -,~=======~  GS. 
k.  s 
o  2'o  .'o  6'0 
Minutes 
± TGA 
DTE 
Fio.  2.  The effect of mild reducing agents (50 mM) on the absorbance at 550 nm of a suspension 
of lens proteins from cataracts of diabetic rat. GSH (glutathione), DMS (dimereaptosuecinic acid), 
PA (Penicillamine), TGA (thioglyeolic acid), DTE (dithloerythritol).  The control was incubated in 
absence of a reducing agent. Control and reduction experiments were performed simultaneously on 
the same batch. 
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FIG. 3.  The effect ofglutathione (O) and dithioerythritol (A) on the absorbance of a suspension of 
lens proteins from cataracts of galactosernie rats. The control (0) was incubated without reducing 
agent. 
disulfide bonds  as  various  reducing  agents  can  decrease  both  the  amount  of light 
scattering and the amount of high molecular weight protein aggregates. The inability 
of reducing agents to achieve complete clearing of the solution and disaggregation of 
the aggregates can be explained by incomplete cleavage of disulfide bonds, noncova- 
lent  aggregation,  or  nondisulfide  protein  crosslinks.  Covalent  bonds  other  than 
disulfide bonds have been noted in human cataracts as well (6). 
The  mechanisms  leading to  sulfhydryl oxidation  are  of obvious  interest  for  the 
formation  of  high  molecular  weight  aggregates.  One  mechanism  based  on  our 
observation in vitro (16) would be that the nonenzymatic glycosylation imparts to the 
lens proteins an increased susceptibility to sulfhydryl oxidation and the formation of 
disulfide  bonds.  It  is  possible  that' the  modification  of  amino  groups  leads  to  a 
conformational  change  of  the  protein  molecule  and  an  unmasking  of sulfhydryl 
groups. Other evidence supporting the importance of amino groups  in maintaining 
the state of the crystallin molecules is the fact that chronic administration of cyanate, 
a  carbamylating  agent,  leads  to  cataract  formation  in  humans  and  experimental 
animals (19)  that are morphologically similar to diabetic cataracts. 
The nonenzymatic glycosylation is probably only one of several factors involved in 
cataract formation in diabetes and galactosemia. Indeed, the more rapid onset of the 
galactosemic cataract with less modification of lysine residues than in diabetes points 1 104  PROTEIN  MODIFICATION IN  SUGAR  CATARACTS 
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Flc.  5.  The elution profile from sucrose gradient  centrifugation of normal  (O)  and cataractous 
(0) lens from galactosemic rats. The lens supernate in 0.1  M  Tris, pH 8.3, was layered on top of a 
5-60%  linear sucrose gradient.  Centrifugation  was performed  for  18  h  at  27,000  rpm at  20°C, 
Adenovirus and SV40 were used as molecular weight markers. MONNIER,  STEVENS,  AND  CERAMI 
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FIQ.  7.  Gel filtration chromatography on Sepharose 2B of the soluble nonreduced (O) and with 50 
mM DTE reduced (O)  fraction from cataractous lenses of galactosemic rats. 
to the role of other factors in hastening cataractogenesis in galactosemia. The ability 
of the  lens  to  maintain  a  reducing  environment  is  probably  critical  for  cataract 
formation  and  can  significantly  affect  the  time of onset  of cataract  formation.  It 
would  appear that  in  addition  to  leading  to  the  glycosylation of lens  protein,  the 
galactosemic state causes a  more rapid  deterioration  than  the diabetic state in  the 
ability of the cell to maintain glutathione  levels which combat sulfhydryl oxidation 
and protein aggregation. The fact that aldose reductase inhibitors can retard but not 
prevent cataract formation suggests that these agents could retard the fall in gluta- 1106  PROTEIN  MODIFICATION IN SUGAR CATARACTS 
thione  levels.  However, the  demand  for reduced  glutathione  is eventually so over- 
whelming that protein aggregation proceeds. With  this respect, the ability of aldose 
reductase inhibitors to scavenge radicals (20)  could be of importance in maintaining 
glutathione levels. This is substantiated by the recent observation by Creighton and 
Trevithick  (21)  that  glutathione  and  antioxidants  could prevent cortical  cataracto- 
genesis under high glucose environment in vitro. 
From the studies  reported here it appears that once lens protein aggregates have 
formed, glutathione  is not very effective in breaking protein-protein  disulfide bonds 
in vitro. This points to the possible use of exogenous agents to prevent or decrease the 
opacity of cataracts in vivo. 
Summary 
The formation of sugar cataracts has been hypothesized to involve the nonenzymatic 
glycosylation,  sulfhydryl  oxidation,  and  aggregation  of lens  proteins.  Cataractous 
lenses of diabetic and galactosemic rats were analyzed for glycosylated lysine residues 
in  crystallins.  A  five-  and  a  ten-fold  increase  in  glycosylated  lysine  residues  was 
measured  in  galactose  and  diabetic  cataracts,  respectively.  The  modification  was 
predominant in the insoluble fraction of the lens homogenate. 
The proteins were further examined  for the presence of disulfide bonds and high 
molecular  weight  aggregates.  After  careful  disruption  of  the  lens  in  a  nitrogen 
environment, a cloudy solution was obtained from cataractous lenses whereas a clear 
solution was obtained from normal lenses. The absorbance at 550 nm of the solution 
of both the galactosemic and the diabetic cataracts could be decreased by ~50% with 
the  addition  of dithioerythritol  (50  raM).  The  presence  of high  molecular weight 
aggregates  was  ascertained  by  sucrose  gradient  centrifugation  and  gel  filtration 
chromatography. The proteins were heterogenous in size and showed a mol wt range 
of 36  to  >176  million  daltons.  Treatment  with  dithioerythritol  induced  a  marked 
decrease in the amount of high molecular weight proteins. 
These data suggest that sugar cataracts of experimental animals have, in common 
with human cataracts, the presence of high molecular weight aggregates which are in 
part linked by disulfide bonds. 
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